Key Events This Week
2 Mar: Stock hits new 52-week and all-time low at Rs.227.95
4 Mar: Technical downgrade to Sell rating amid bearish momentum
6 Mar: Week closes at Rs.259.25, down 3.08% on the day
Mar 06
BSE+NSE Vol: 15.44 k
2 Mar: Stock hits new 52-week and all-time low at Rs.227.95
4 Mar: Technical downgrade to Sell rating amid bearish momentum
6 Mar: Week closes at Rs.259.25, down 3.08% on the day

Suraksha Diagnostic Ltd, a key player in the Healthcare Services sector, has experienced a notable shift in its technical momentum, prompting a downgrade in its Mojo Grade from Hold to Sell as of 11 Aug 2025. The stock’s recent price action and technical indicators suggest a transition from a sideways trend to a bearish outlook, reflecting growing investor caution amid broader market pressures.
Read full news article
Recent Price Movement and Market Comparison
Suraksha Diagnostic Ltd has experienced a notable decline over the past week, with the stock losing 6.54% compared to the Sensex’s 3.67% fall. Although the stock’s one-month performance of -1.65% is roughly in line with the Sensex’s -1.75%, the year-to-date return of -0.95% contrasts with the broader market’s sharper 5.85% decline, indicating relative resilience. However, over the last year, the stock’s 2.17% gain significantly trails the Sensex’s 9.62% rise, highlighting underperformance against the benchmark.
On 02-Mar, the stock opened sharply lower, down 16.03%, and traded within a wide intraday range of ₹40.85, touching the low of ₹227.95. The weighted average price suggests that most trading volume occurred near the day...
Read full news article
Suraksha Diagnostic Ltd’s shares declined sharply to a new 52-week low of Rs.227.95 on 2 Mar 2026, marking a significant drop amid a five-day losing streak that has seen the stock fall by 6.56%. This decline comes despite a broader market recovery, with the Sensex rebounding after an initial gap down opening.
Read full news article
Suraksha Diagnostic Ltd, a player in the healthcare services sector, has reached a new all-time low price of Rs. 227.95, marking a significant decline amid a period of sustained underperformance relative to the broader market and its sector peers.
Read full news article
Suraksha Diagnostic Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an attractive rating, driven primarily by changes in its price-to-earnings and price-to-book value ratios. This development comes amid a mixed performance backdrop and evolving market sentiment within the healthcare services sector.
Read full news article
Suraksha Diagnostic Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 February 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
Suraksha Diagnostic Ltd has seen a notable shift in its valuation parameters, moving from a fair to an attractive rating, despite a recent downgrade in its overall Mojo Grade to Sell. This change reflects evolving market perceptions amid mixed returns relative to the broader Sensex, highlighting a nuanced investment case for healthcare services investors.
Read full news article
Suraksha Diagnostic Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 February 2026, providing investors with the most up-to-date insight into the company’s performance and outlook.
Read full news articleIntimation of the schedule of Analysts/ Institutional Investors/ Organisations meeting to be held on Monday 09 March 2026 at 10:00 am
Intimation of resignation of Mr. K S Ravindra Group Chief Financial Officer (CFO) designated as Key Managerial Personnel (KMP) of the Company
Please find the enclosed transcript of the Earnings Call held on Friday 06 February 2026 at 02:30 pm.
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available